The focus of Enzymicals
is the development, production and utilisation of innovative biocatalysts. We cover the entire value chain from bio- catalyst discovery via their optimisation by protein engineering tools to the efficient application in biocatalysis. This includes the development of economic processes as well as the production of high value building blocks and chemicals using tailor-made processes.
The main focus herein is the industrial application of biocatalytic syntheses for a resource friendly chemistry.

Captions are given in related document.

January 17th 2012
Enzymicals AG and Herbrand PharmaChemicals GmbH cooperate for biotechno- logical production of pharmaceuticals and intermediates
Document - Image 1 - Image 2

June 21st 2011
Enzymicals AG and Lonza AG sign license agreement for the global use of (R)-selective transaminases in laboratory scale in Lonza patented processes.
Document - Image 1 - Image 2

June 1st 2011
White meets blue. Enzymicals AG and the Institute of Marine Biotechnology e.V. are going to cooperate in the areas of white and blue biotechnology.
Document - Image 1

October 4th 2010
Enzymicals AG acquires proprietary rights on pig liver esterases (PLE) from Evonik AG.
Document - Image 1

July 12th 2010
BRAIN AG acquires share in chemical and biocatalyst specialist Enzymicals AG.
Document - Image 1 - Image 2 - Image 3

Published Articles

ChemBioTec Review 003
Company profile (available in German)
Article

transkript 8-9/2010
BRAIN invests in fine chemicals specialist (available in German)
Article

BIOspektrum 06.10
Enzymicals AG: Academic spin-off with high ambitions (available in German)
Article